Cagigi, Alberto <br/><br/>
Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.  [electronic resource] 

 -  The Pediatric infectious disease journal  May 2014 
 - e126-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-0987 
<br/><br/><label>Standard No.: </label>10.1097/INF.0000000000000144  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Anti-Retroviral Agents--administration & dosage<br/>Antibodies--blood<br/>Antiretroviral Therapy, Highly Active--methods<br/>B-Lymphocytes--immunology<br/>Cell Survival<br/>Child<br/>Enzyme-Linked Immunosorbent Assay<br/>Enzyme-Linked Immunospot Assay<br/>Female<br/>Flow Cytometry<br/>Follow-Up Studies<br/>HIV Infections--drug therapy<br/>Humans<br/>Male<br/>Time Factors<br/>Vaccines--administration & dosage<br/>Young Adult